These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2528239

  • 1. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI.
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract] [Full Text] [Related]

  • 2. [Hormonal control of disseminated breast cancer].
    Voznyĭ EK, Meshcheriakova NG, Biakhov MIu, Vasiuta NIu.
    Sov Med; 1990; (6):94-7. PubMed ID: 2144368
    [No Abstract] [Full Text] [Related]

  • 3. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK, Titova VA.
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
    Pannuti F, Martoni A, Piana E, Tomasi L, Grieco A, Farris A, Saccani F, Baroni M.
    Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L, Ausilli-Cefaro GP, Turriziani A, Saccheri S, Venturo I, Minotti G.
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract] [Full Text] [Related]

  • 8. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F, Martoni A, Fruet F, Strocchi E, Di Marco AR.
    Eur J Cancer (1965); 1980 Oct; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapy and endocrine therapy in metastatic disease.
    Pritchard KI.
    Curr Opin Oncol; 1989 Dec; 1(2):324-32. PubMed ID: 2489975
    [No Abstract] [Full Text] [Related]

  • 12. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
    Jouve M, Palangie T, Bretaudeau B, Garcia-Giralt E, Asselain B, Magdelenat H, Pouillart P.
    Bull Cancer; 1984 Dec; 71(2):148. PubMed ID: 6733294
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y, Tashiro H, Hisamatsu K, Toi M.
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [Abstract] [Full Text] [Related]

  • 14. [Endocrine therapy in breast carcinoma].
    Dogliotti L, Maschietto M, Ortega C.
    Minerva Chir; 1988 Sep 30; 43(18 Suppl):63-6. PubMed ID: 3067123
    [No Abstract] [Full Text] [Related]

  • 15. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E, Jouve M, Palangie T, Bretaudeau B, Asselain B, Magdelenat H, Merle S, Zajdela A, Pouillart P.
    Bull Cancer; 1984 Sep 30; 71(1):22-9. PubMed ID: 6324934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer.
    Stotter A.
    Eur J Surg Oncol; 1999 Aug 30; 25(4):341-3. PubMed ID: 10419700
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
    Possinger K, Wagner H, Langecker P, Schmid L, Willich S, Wilmanns W.
    Fortschr Med; 1987 Jul 30; 105(22):421-4. PubMed ID: 2958397
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.